A recovery room scam is cloning Opus Capital. Meanwhile Paul Seakens, director of Opus Capital (previously known as Carbon Neutral Investments) was hired in 2014 to advise Thorn Medical, a stem cell research medical company, whose directors now include Lord Beaverbrook, Sir John Lucas-Tooth, and Sir Eric Peacock

Opus CapitalIn February 2016, the High Court in London ordered 19 companies into liquidation. One of the companies was CNI (UK) Ltd, one of three companies that emerged in 2013 from the ashes of Carbon Neutral Investments, a company involved in selling carbon credits to retail investors.

Continue reading